Suppr超能文献

Inlow 60 秒糖尿病足筛查工具的信度和预测效度。

Reliability and predictive validity of Inlow's 60-Second Diabetic Foot Screen Tool.

机构信息

The Ottawa Hospital, Ottawa, Ontario, Canada.

出版信息

Adv Skin Wound Care. 2012 Jun;25(6):261-6. doi: 10.1097/01.ASW.0000415343.45178.91.

Abstract

OBJECTIVE

: The purpose of this study was to assess Inlow's 60-Second Diabetic Foot Screen Tool to ascertain consistency of risk recognition for development of ulceration independent of specific assessor and practice setting. Screening tools that assist clinicians in identifying risk require validation. The objectives were to determine the intrarater reliability, interrater reliability, and predictive validity of Inlow's 60-Second Diabetic Foot Screen Tool in 2 healthcare settings.

DESIGN

: Following ethics board approval, a prospective observational study was completed.

SETTING AND PARTICIPANTS

: A convenience sample of 69 persons with diabetes was recruited: n = 26 from an acute care setting (dialysis) and n = 43 from long-term-care (LTC) setting.

MAIN OUTCOME MEASURES

: The screening tool was administered by 2 assessors independently to determine interrater reliability and later the same day by one of the assessors to determine intrarater reliability. Occurrence of foot ulcers or amputation was noted 1 to 5 months later to determine predictive validity.

MAIN RESULTS

: Reliability is reported per setting using the intraclass correlation coefficient (2.1) and 95% confidence intervals. Intrarater reliability: LTC 0.96 (0.93-0.98) right foot, 0.97 (0.95-0.98) left foot; dialysis 1.00 right and 1.00 left foot. Interrater reliability: LTC 0.92 (0.86-0.96) right foot, 0.93 (0.87-0.96) left foot; dialysis 0.83 (0.65-0.92) right foot and left foot. Predictive validity: Two subjects had events-1 ulcer and 1 amputation-that were associated with high Inlow's screening tool scores.

CONCLUSION

: This study demonstrates excellent interrater and intrarater reliability and provides preliminary information about predictive validity.

摘要

目的

本研究旨在评估 Inlow 的 60 秒糖尿病足筛查工具,以确定其在特定评估者和实践环境之外识别溃疡发生风险的一致性。用于协助临床医生识别风险的筛查工具需要进行验证。目的是确定该工具在 2 种医疗环境中的组内信度、组间信度和预测效度。

设计

在获得伦理委员会批准后,进行了一项前瞻性观察性研究。

地点和参与者

从急性护理环境(透析)和长期护理(LTC)环境中分别招募了方便样本的 69 名糖尿病患者:n = 26 和 n = 43。

主要观察指标

由 2 名评估者独立进行筛查工具评估以确定组间信度,之后在同一天由其中一名评估者进行评估以确定组内信度。在 1 至 5 个月后记录足部溃疡或截肢的发生情况以确定预测效度。

主要结果

根据设置使用组内相关系数(2.1)和 95%置信区间报告可靠性。组内信度:LTC 右脚 0.96(0.93-0.98),左脚 0.97(0.95-0.98);透析右脚和左脚均为 1.00。组间信度:LTC 右脚 0.92(0.86-0.96),左脚 0.93(0.87-0.96);透析右脚和左脚均为 0.83(0.65-0.92)。预测效度:2 名受试者发生了事件——1 例溃疡和 1 例截肢——与较高的 Inlow 筛查工具评分相关。

结论

本研究表明该工具具有极好的组内信度和组间信度,并提供了预测效度的初步信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验